Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Cortical Excitability and Inhibition in Children and Adolescents With Major Depressive Disorder
Cortical Excitability and Inhibition in Children and Adolescents With Major Depressive Disorder
Status: Enrolling
Updated:  5/8/2009
UT Southwestern Medical Center
mi
from
Dallas, TX
Cortical Excitability and Inhibition in Children and Adolescents With Major Depressive Disorder
Cortical Excitability and Inhibition in Children and Adolescents With Major Depressive Disorder
Status: Enrolling
Updated: 5/8/2009
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?
Memantine Augmentation of Electroconvulsive Therapy in Patients With Major Depression
Status: Enrolling
Updated:  10/1/2009
University of Iowa hosptitals and clinic
mi
from
Iowa City, IA
The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?
Memantine Augmentation of Electroconvulsive Therapy in Patients With Major Depression
Status: Enrolling
Updated: 10/1/2009
University of Iowa hosptitals and clinic
mi
from
Iowa City, IA
Click here to add this to my saved trials
Clinical and Biological Characteristics of Psychotic Depression
Hypothalamic-Pituitary-Adrenal (HPA)/ Dopamine Axis in Psychotic Depression
Status: Enrolling
Updated:  2/9/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Clinical and Biological Characteristics of Psychotic Depression
Hypothalamic-Pituitary-Adrenal (HPA)/ Dopamine Axis in Psychotic Depression
Status: Enrolling
Updated: 2/9/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study
Status: Enrolling
Updated:  10/8/2010
University of Alabama at Birmingham
mi
from
Birmingham, AL
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study
Status: Enrolling
Updated: 10/8/2010
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study
Status: Enrolling
Updated:  10/8/2010
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study
Status: Enrolling
Updated: 10/8/2010
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study
Status: Enrolling
Updated:  10/8/2010
University of Michigan
mi
from
Ann Arbor, MI
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study
Status: Enrolling
Updated: 10/8/2010
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study
Status: Enrolling
Updated:  10/8/2010
Baylor Institute for Rehabilitation
mi
from
Dallas, TX
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study
Status: Enrolling
Updated: 10/8/2010
Baylor Institute for Rehabilitation
mi
from
Dallas, TX
Click here to add this to my saved trials
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study
Status: Enrolling
Updated:  10/8/2010
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study
Status: Enrolling
Updated: 10/8/2010
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)
Personalized Response Indicators of SSRI Effectiveness in Major Depression
Status: Enrolling
Updated:  10/15/2010
UCLA Semel Institute
mi
from
Los Angeles, CA
Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)
Personalized Response Indicators of SSRI Effectiveness in Major Depression
Status: Enrolling
Updated: 10/15/2010
UCLA Semel Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Biomarkers for Outcomes In Late-life Depression (BOLD)
Biomarkers for Outcomes In Late-life Depression
Status: Enrolling
Updated:  10/15/2010
UCLA Semel Institute
mi
from
Los Angeles, CA
Biomarkers for Outcomes In Late-life Depression (BOLD)
Biomarkers for Outcomes In Late-life Depression
Status: Enrolling
Updated: 10/15/2010
UCLA Semel Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
Status: Enrolling
Updated:  11/1/2010
Psychiatric Hospital at Vanderbilt
mi
from
Nashville, TN
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
Status: Enrolling
Updated: 11/1/2010
Psychiatric Hospital at Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials
Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
An Open-label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines in Treatment-refractory Patients With Unipolar Depression or Generalized Anxiety Disorder and Chronic Benzodiazepine Use
Status: Enrolling
Updated:  11/18/2010
Weill Medical College of Cornell University
mi
from
New York, NY
Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
An Open-label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines in Treatment-refractory Patients With Unipolar Depression or Generalized Anxiety Disorder and Chronic Benzodiazepine Use
Status: Enrolling
Updated: 11/18/2010
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
T- BOOM Teens--Building Options and Opportunities for Moms
Teens--Building Options and Opportunities for Moms
Status: Enrolling
Updated:  2/16/2011
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
T- BOOM Teens--Building Options and Opportunities for Moms
Teens--Building Options and Opportunities for Moms
Status: Enrolling
Updated: 2/16/2011
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Increasing Use of Mental Health Services
Increasing Use of Mental Health Services by Community Dwelling Adults With Depression
Status: Enrolling
Updated:  2/18/2011
Weill Cornell Medical College
mi
from
White Plains, NY
Increasing Use of Mental Health Services
Increasing Use of Mental Health Services by Community Dwelling Adults With Depression
Status: Enrolling
Updated: 2/18/2011
Weill Cornell Medical College
mi
from
White Plains, NY
Click here to add this to my saved trials
Neurophysiologic Predictors of Outcome With rTMS Treatment of Major Depressive Disorder
Neurophysiologic Predictors of Outcome With rTMS Treatment of Major Depressive Disorder
Status: Enrolling
Updated:  4/4/2011
UCLA Depression Research and Clinic Program
mi
from
Los Angeles, CA
Neurophysiologic Predictors of Outcome With rTMS Treatment of Major Depressive Disorder
Neurophysiologic Predictors of Outcome With rTMS Treatment of Major Depressive Disorder
Status: Enrolling
Updated: 4/4/2011
UCLA Depression Research and Clinic Program
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Depression Treatment for Low Income Substance Users
Depression Treatment for Urban Low Income Minority Substance Users
Status: Enrolling
Updated:  5/9/2011
Salvation Army Harbor Light Treatment Center
mi
from
Washington,
Depression Treatment for Low Income Substance Users
Depression Treatment for Urban Low Income Minority Substance Users
Status: Enrolling
Updated: 5/9/2011
Salvation Army Harbor Light Treatment Center
mi
from
Washington,
Click here to add this to my saved trials
Depression Treatment for Low Income Substance Users
Depression Treatment for Urban Low Income Minority Substance Users
Status: Enrolling
Updated:  5/9/2011
The University of Maryland
mi
from
College Park, MD
Depression Treatment for Low Income Substance Users
Depression Treatment for Urban Low Income Minority Substance Users
Status: Enrolling
Updated: 5/9/2011
The University of Maryland
mi
from
College Park, MD
Click here to add this to my saved trials
Behavioral Depression Treatment for African American HIV-infected Substance Users
Behavioral Depression Treatment for African American HIV-infected Substance Users
Status: Enrolling
Updated:  5/10/2011
Salvation Army Harbor Light Treatment Center
mi
from
Washington,
Behavioral Depression Treatment for African American HIV-infected Substance Users
Behavioral Depression Treatment for African American HIV-infected Substance Users
Status: Enrolling
Updated: 5/10/2011
Salvation Army Harbor Light Treatment Center
mi
from
Washington,
Click here to add this to my saved trials
Behavioral Depression Treatment for African American HIV-infected Substance Users
Behavioral Depression Treatment for African American HIV-infected Substance Users
Status: Enrolling
Updated:  5/10/2011
The University of Maryland
mi
from
College Park, MD
Behavioral Depression Treatment for African American HIV-infected Substance Users
Behavioral Depression Treatment for African American HIV-infected Substance Users
Status: Enrolling
Updated: 5/10/2011
The University of Maryland
mi
from
College Park, MD
Click here to add this to my saved trials
Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions
Escitalopram (Lexapro) for the Treatment of TBI Depression and Other Comorbid Psychiatric Conditions
Status: Enrolling
Updated:  6/7/2011
Johns Hopkins University
mi
from
Baltimore, MD
Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions
Escitalopram (Lexapro) for the Treatment of TBI Depression and Other Comorbid Psychiatric Conditions
Status: Enrolling
Updated: 6/7/2011
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Neural Correlates of Psychodynamic Psychotherapy for Depression
Neural Correlates of Psychodynamic Psychotherapy for Depression
Status: Enrolling
Updated:  6/10/2011
Depression Clinical and Research Program
mi
from
Boston, MA
Neural Correlates of Psychodynamic Psychotherapy for Depression
Neural Correlates of Psychodynamic Psychotherapy for Depression
Status: Enrolling
Updated: 6/10/2011
Depression Clinical and Research Program
mi
from
Boston, MA
Click here to add this to my saved trials
The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
Status: Enrolling
Updated:  6/28/2011
Weill-Cornell Medical College
mi
from
New York, NY
The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
Status: Enrolling
Updated: 6/28/2011
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder : A 13-week, Double-Blind, Placebo-Controlled, Cross-Over Trial
Status: Enrolling
Updated:  7/26/2011
Tufts Medical Center
mi
from
Boston, MA
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder : A 13-week, Double-Blind, Placebo-Controlled, Cross-Over Trial
Status: Enrolling
Updated: 7/26/2011
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder : A 13-week, Double-Blind, Placebo-Controlled, Cross-Over Trial
Status: Enrolling
Updated:  7/26/2011
Duke University School of Medicine
mi
from
Durham, NC
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder : A 13-week, Double-Blind, Placebo-Controlled, Cross-Over Trial
Status: Enrolling
Updated: 7/26/2011
Duke University School of Medicine
mi
from
Durham, NC
Click here to add this to my saved trials
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder : A 13-week, Double-Blind, Placebo-Controlled, Cross-Over Trial
Status: Enrolling
Updated:  7/26/2011
University of South Carolina
mi
from
West Columbia, SC
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder : A 13-week, Double-Blind, Placebo-Controlled, Cross-Over Trial
Status: Enrolling
Updated: 7/26/2011
University of South Carolina
mi
from
West Columbia, SC
Click here to add this to my saved trials
Oxytocin Add-on for Stable Depressed Patients
Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study of Intranasal Oxytocin Augmentation of Antidepressant Medication in Depressed Patients.
Status: Enrolling
Updated:  8/8/2011
UCSD Medical Center
mi
from
San Diego, CA
Oxytocin Add-on for Stable Depressed Patients
Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study of Intranasal Oxytocin Augmentation of Antidepressant Medication in Depressed Patients.
Status: Enrolling
Updated: 8/8/2011
UCSD Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Birmingham Research Group
mi
from
Birmingham,, AL
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Birmingham Research Group
mi
from
Birmingham,, AL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Sun Valley Behavioral Medical
mi
from
Imperial, CA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Sun Valley Behavioral Medical
mi
from
Imperial, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Synergy Clinical Research Center
mi
from
National City, CA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Synergy Clinical Research Center
mi
from
National City, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Excell Research, Inc.
mi
from
Oceanside, CA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Pacific Clinical Research Medical Group
mi
from
Orange, CA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Pacific Clinical Research Medical Group
mi
from
Orange, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
SMRI
mi
from
Sherman Oaks, CA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
SMRI
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Sarkis Clinical Trials
mi
from
Gainesville, FL
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Sarkis Clinical Trials
mi
from
Gainesville, FL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Florida Research Center
mi
from
Maitland, FL
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Florida Research Center
mi
from
Maitland, FL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
University of Miami, Miller School
mi
from
Miami, FL
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
University of Miami, Miller School
mi
from
Miami, FL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Miami Research
mi
from
Miami, FL
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Miami Research
mi
from
Miami, FL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Comprehensive NeuroScience, Inc.
mi
from
Atlanta, GA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Comprehensive NeuroScience, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Hawaii Clinical Research Center
mi
from
Honolulu, HI
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Hawaii Clinical Research Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Psychiatric Medicine Associates
mi
from
Skokie, IL
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Psychiatric Medicine Associates
mi
from
Skokie, IL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
CRI Worldwide
mi
from
Mt Laurel, NJ
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
CRI Worldwide
mi
from
Mt Laurel, NJ
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Montefiore Medical Center; Anxiety & Depression Clinic; Dept. of Psychiatry
mi
from
Bronx, NY
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Montefiore Medical Center; Anxiety & Depression Clinic; Dept. of Psychiatry
mi
from
Bronx, NY
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Medical & Behavioral Health Research
mi
from
New York, NY
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Medical & Behavioral Health Research
mi
from
New York, NY
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
New Hope Clinical Research
mi
from
Hickory, NC
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
New Hope Clinical Research
mi
from
Hickory, NC
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Sooner Clinical Research
mi
from
Oklahoma City, OK
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Sooner Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Lehigh Center for Clinical Research
mi
from
Allentown, PA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Lehigh Center for Clinical Research
mi
from
Allentown, PA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Suburban Research Associates
mi
from
Media, PA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Harry Croft and Associates
mi
from
San Antonio, TX
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Harry Croft and Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
University of Texas Health Science Center
mi
from
San Antonio, TX
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials